Brain Cancer Trial, Recruiting NCT07459101 Sponsor: Sunnybrook Health Sciences Centre Condition: Brain Cancer
Back to Brain Cancer

Brain Cancer Trial, Recruiting

NCT07459101
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with glioblastoma or a grade 4 astrocytoma (a type of brain tumour), confirmed through a biopsy or surgical removal of tumour tissue
  • People whose doctors have determined that combined chemotherapy and radiation treatment (using a drug called temozolomide) is an appropriate treatment plan for them
  • People who had their biopsy or tumour surgery no more than 12 weeks before joining the study
  • People whose doctors expect them to live for at least 12 weeks
  • People who are reasonably physically functional — able to carry out some daily activities, even if not fully active (this is measured on a standard scale called ECOG, scores 0, 1, or 2)
  • People whose kidneys are working well enough to safely receive a contrast dye used in MRI scans (people with lower kidney function may still be considered after discussion with the study team)
  • People who are able to attend all required treatment appointments and follow-up visits
  • People who have signed a written consent form agreeing to take part
  • People with tumours that have spread to more than one area of the brain may be considered, at the treating radiation oncologist's discretion

Who may not be able to join:

  • People who cannot have an MRI scan for any standard medical reason
  • People who cannot safely receive the contrast dye used in MRI scans
  • People whose tumour shows signs of involvement in the brainstem on MRI scans, if they are being considered for the shorter 15-session radiation treatment course
  • People who are unable to lie flat on their back for at least 30 minutes
  • People who are unable to tolerate wearing a fitted plastic mask used to keep the head still during radiation treatment
  • People who weigh more than 140 kg or whose head/neck circumference is larger than 60 cm (due to MRI scanner size limits)
  • People who have previously had radiation treatment to the brain
  • People whose tumour has spread along the lining of the brain or spinal cord
  • People with a history of another cancer, unless it was a common skin cancer (non-melanoma), or another cancer that was fully treated with no signs of return for at least 2 years
  • People with any condition — physical, psychological, or related to their location or circumstances — that would make it difficult for them to follow the study requirements

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 416-480-6100

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
10 September 2025
Est. completion
1 October 2029

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Disease worsening at 6 months

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov